AstraZeneca, one of the world’s leading pharmaceutical companies, has announced a transformative acquisition of the Belgium-based biotech firm Esobiotec in a deal worth up to $1 billion. This strategic move
AstraZeneca, one of the world’s leading pharmaceutical companies, has announced a transformative acquisition of the Belgium-based biotech firm Esobiotec in a deal worth up to $1 billion. This strategic move






